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Background: Non-syndromic cleft lip with or without cleft palate (NSCL/P) is among the most common congeni-
tal malformations. The etiology of NSCL/P remains poorly characterized owing to its complex genetic heteroge-
neity. The objective of this study was to identify genetic variants that increase susceptibility to NSCL/P. 
Material and Methods: Whole-exome sequencing (WES) was performed in 8 fetuses with NSCL/P in China. 
Bioinformatics analysis was performed using commercially available software. Variants detected by WES were 
validated by Sanger sequencing.
Results: By filtering out synonymous variants in exons, we identified average 8575 nonsynonymous single nucle-
otide variants (SNVs). We subsequently compared the SNVs against public databases including NCBI dbSNP 
build 135 and 1000 Genomes Project and obtained an average of 203 SNVs. Total 12 reported candidate genes 
were verified by Sanger sequencing. Sanger sequencing also confirmed 16 novel SNVs shared by two or more 
samples.
Conclusions: We have found and confirmed 16 susceptibility genes responsible for NSCL/P, which may play im-
portant role in the etiology of NSCL/P. The susceptibility genes identified in this study will not only be useful in 
revealing the etiology of NSCL/P but also in diagnosis and treatment of the patients with NSCL/P. 
Key words: Non-syndromic cleft lip with or without cleft palate, whole-exome sequencing, sanger sequencing, 
susceptibility gene, single nucleotide variants (SNVs).
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Introduction
Non-syndromic cleft lip with or without cleft palate 
(NSCL/P) is one of the most common human birth de-
fects in all populations worldwide. The average birth 
prevalence of NSCL/P is estimated to be 1/700 rang-
ing from 1/500 to 1/1,000, depending on the economic, 
geographical, and genetic back-ground variation (1). In-
dividuals with NSCL/P may experience problems with 
feeding, digesting, speaking, hearing and social en-
gagement which can be corrected to varying degrees 
by multiple rounds of surgical repair along with dental 
treatment, speech therapy and psychosocial interven-
tion from birth until adulthood. Furthermore, affected 
children have higher morbidity and mortality through-
out life than do unaffected individuals (2). Therefore, 
NSCL/P will bring substantial psychosocial and finan-
cial burdens to individuals, their families, and society, 
which creates a major social problem (3). 
The etiology of NSCL/P has been a focus area of re-
search for centuries. The etiology of NSCL/P is com-
plex and is currently considered to be due to a combi-
nation of both environmental and genetic factors (4), 
which is distinct from that of syndromic CL/P (SCL/P). 
SCL/P has been shown to associate with single-gene 
mutations, chromosomopathies, and exposure to terato-
gens (5). However, the etiology of NSCL/P remains 
unknown because of its etiologic complexity (6). Fur-
thermore, NSCL/P is the most prevalent type of CL/P 
and approximately 70% of cases are considered to be 
NSCL/P (7,8). Therefore, more studies are necessary 
to elucidate genetic risk factors related to NSCL/P. To 
date, approaches to uncover genetic determinants con-
trolling risk of NSCL/P include linkage analysis, asso-
ciation studies, identification of chromosomal anoma-
lies or microdeletions in cases, and direct sequencing 
of DNA samples from affected individuals (9). Various 
loci could have a causal role in NSCL/P including cer-
tain regions of chromosomes 1, 2, 4, 6, 14, 17, and 19 in 
previous human studies (10,11). Variants of candidate 
genes linked to NSCL/P including TGF-α, TGF-β3, 
MSX1, IRF6, TBX22, CYP1A1, MTHFR, and RARA 
have been identified in population-based studies (1,4,12-
14). Although many genes and regions of chromosomes 
have positive results in one or more of the studies, few 
of those findings were consistently positive across all 
studies. 
The methods to genotype all single nucleotide poly-
morphisms (SNPs) using genotyping arrays greatly fa-
cilitate the development and progress of genome-wide 
association studies (GWAS) (15) . GWAS have become 
a powerful and ideal technique in studying complex 
human diseases. To date, there have been a number of 
GWAS for CL/P (16-19). The results of the GWAS are 
encouraging. GWAS are novel and rapidly advancing 
approach in the study of molecular genetics underlying 
human diseases and have led to many exciting discover-
ies. However, traditional array-based GWAS primarily 
test the common disease–common variant hypothesis 
(15). Therefore, GWAS are limited to known and com-
mon variants. Only a fraction of the genetic basis of 
common diseases can currently be explained by associ-
ations with common variants (20). Uncommon and rare 
variants may play a major role in many phenotypes. 
Recently, next-generation sequencing (NGS) technology 
has developed rapidly and has been suggested as a reli-
able method for finding variations associated with vari-
ous disease states. NGS technology enables researchers 
to interrogate the complete human genome or exome for 
the detection of both common and rare variants, hence 
improving the chance of finding disease causal variants 
(21). Whole-exome sequencing (WES) is both a cost-
effective and a time-efficient alternative to whole-ge-
nome sequencing, so the method is becoming a popular 
NGS strategy by capturing and sequencing the ~1% of 
the human genome coding for protein sequences. Ng SB 
and colleagues first showed that WES can be used to 
identify disease genes in 2009 (20). Now, WES has been 
successfully utilized to identify the causative genetic 
variants responsible for Mendelian disorders and com-
plex hereditary diseases (22,23). One recent study has 
conducted a WES study to search for potentially causal 
variants using affected relatives drawn from multiplex 
cleft families (24). The oral cleft families include two of 
Chinese origin (one each from Taiwan and Shanghai) 
with four subjects.
In this study, we conducted WES in eight fetuses with 
NSCL/P in China. The purpose of this study was to il-




Eight fetuses with NSCL/P were recruited from Ma-
ternal and Child Health Hospital of Xuzhou, Jiangsu, 
China. The cases of NSCL/P were diagnosed by prena-
tal B-ultrasonography and confirmed by autopsy. The 
parents of the fetuses were informed of the purpose of 
the study. The signed informed consent sheets were ob-
tained from the parents of all study participants. After 
obtaining informed consent, the lip tissue specimens 
of the fetuses were obtained by sectioning the lip tis-
sue around the cleft of the lip. The study was approved 
by Ethical Committee for Human Research of Xuzhou 
Medical College. 
-DNA preparation and library construction
Genomic DNA was extracted from the tissues using 
QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA) 
according to the manufacturer’s protocols. The quality 
of the DNA sample was ascertained by electrophore-
sis and determined to be of high molecular weight with 
no visible degradation. Quantity was determined using 
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standard PicoGreen assays. A high quality DNA was 
used as the starting material. The DNA was fragmented 
by Bioruptor Sonicator (Diagenode, USA). High-qual-
ity DNA library was constructed from genomic DNA 
using the TruSeq DNA Sample Preparation Kit for end 
repair, dA tailing, adaptor ligation and DNA fragment 
enrichment. 
-Exome capture and Illumina exome sequencing
The TruSeq Exome Enrichment Kit was used to cap-
ture exome sequences from the prepared human DNA 
library. After two rounds hybridization and washing, 
the DNA exome library was captured and enriched. 
The size was checked using a DNA specific chip, the 
Agilent DNA 1000 on Agilent Technologies 2100 Bio-
analyzer (Agilent Technologies, Santa Clara, CA). The 
libraries were quantified using Qubit (Invitrogen, CA, 
USA) according to the manufacturer’s instructions. All 
sequencing of post-enrichment shotgun libraries was 
carried out on the Illumina HiSeq 2000 Analyzers for 
90 cycles per read following the manufacturer’s proto-
cols and using the standard sequencing primer. 
-Data filtering and bioinformatics analysis 
After the entire run was completed, image analyses, er-
ror estimation and base calling were performed using 
the Illumina Pipeline (version 1.3.4) to generate prima-
ry data. Indexed primers were used to identify the dif-
ferent reads from different samples in the primary data. 
Only reads that were perfectly matched to the theoreti-
cal adapter indexed sequences and reads that matched 
the theoretical primer indexed sequences with a maxi-
mum of three mismatches were considered to be accept-
able reads. The local dynamic programming algorithm 
was used to remove a few unqualified sequences from 
the primary data using. 
After filtering, for aligning the sequences to the hu-
man genome, the Burrows-Wheeler Aligner (BWA) 
was used to map short-reads from fastq files against the 
human reference genome. Then, the Genome Analysis 
Toolkit 1.6 (GATK) was applied to carry out regional 
realignment and quality score recalibration and Picard-
was applied to mark duplicates. Variants were called 
using the GATK variant calling program (Fig. 1). The 
ANNOVAR (Annotate Variation) was used to annotate 
possible mutation candidates. The variants were com-
pared with NCBI dbSNP 135 and 1000 Genomes Proj-
ect reported SNP to remove the published variants. 
-Sanger sequencing
The Sanger DNA sequencing method has been consid-
Fig. 1. Variants analysis strategy for NSCL/P using GATK tools. Data analysis process was carried out according to step 1-4 
including initial mapping, refinement of the initial reads, multi-sample indel and SNP calling and quality score recalibration in 
phase 1-3 including NGS data processing, variants discovery and genetyping and integrative analysis. The SNPs in the exomes 
were identified. 
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ered to represent the gold standard for screening vari-
ants of genes of interest in many scientific fields. In this 
study, to verify the DNA sequence variants detected 
by WES, the variants of the affected individuals were 
sequenced using Sanger sequencing. The primers were 
designed for the target region using Primer 6.0. All ex-
ons of selected genes were amplified. The PCR products 
were sequenced on an ABI 3730 DNA analyzer follow-
ing standard procedures (Life Technologies, USA). The 
sequence reads were analyzed using the Sequencher 
software package (GeneCodes Inc, USA). All sequence 
traces were manually reviewed to ensure the reliability 
of the genotype calls. The sequencing traces were visu-
ally inspected in Finch TV v1.4 (Geospiza Inc, USA).
 
Results
A strategy of WES by hybrid capture was employed (Ta-
ble 1). The average total effective data were 12.4 billion 
Sample 1 2 3 4 5 6 7 8 Mean 
Total effective data (Gb) 13.68 13.85 14.17 13.40 11.80 11.31 11.79 9.16 12.40 
Ratio  alignment to reference 
genome(%)
96.0 96.1 96.1 97.0 93.4 96.0 91.5 87.2 94.2 
Capture efficiency (%) 62.8 62.5 62.7 60.9 85.0 61.2 62.8 56.9 56.0 
Mean coverage sequencing depth 116 116 120 110 95 96 89 67 101.1 
Coverage of target region (%) 95.3 95.3 95.3 95.9 95.0 95.3 94.7 93.7 95.8 
Fraction of official target covered 
with at least 4X (%) 
93.52 93.38 93.58 93.98 93.19 93.33 92.44 91.03 93.06 
Fraction of official target covered 
with at least 10X (%) 
91.39 91.27 91.43 91.84 90.58 90.99 89.46 86.88 90.48 
Fraction of official target covered 
with at least 20X (%) 
87.97 87.45 88.03 88.52 86.10 87.08 84.15 79.15 86.06 
Table 1. Quality evaluation of whole-exome sequencing.
base pairs (Gb). The average ratio of reads alignment to 
reference genome was 94.2%. On average, the efficien-
cy of the hybrid capture was 60.7%. When measured 
at a minimum depth of 4×, 93.1% of the target region 
was covered. Likewise, when measured at 10× and 20×, 
90.5% and 86.1% of the intended target was covered, 
respectively. The average mean coverage sequencing 
depth on official target was 101.1-fold and with 95.8% 
fraction of official target covered. Thus, the depth and 
coverage should be adequate to reliably detect DNA 
variants within the majority of the targeted regions.
An average of 138766 high-confidence single nucleotide 
variants (SNVs) per sample was found after the appli-
cation of initial quality filtering criteria (coverage≥5X 
and SNP quality score≥40) following the manufactur-
er’s protocols. Then, we used the analytical procedures 
to significantly reduce the candidate list and focus on 
variants that were most likely to be relevant to NSCL/P. 
On average, a total 18759 SNVs per sample remained 
after filtering the SNVs not in exons. By filtering out 
synonymous variants in the coding region unlikely to 
be disease-causing variants, average 8575 exon non-
synonymous SNVs remained predicted to change an 
amino acid or a consensus splice site. The variant of 
IRF6, a known gene causing NSCL/P (12,14,25) , was 
included in these variants. Several other reported candi-
date genes including CRISPLD2, MYH9, PDGF-C and 
ABCA4 were also identified (16,26-28). NCBI dbSNP 
135 and 1000 Genomes Project were utilized for filter-
ing variants to remove presumably common variants. 
Each sequenced individual harbored an average 203 
SNVs ranging form 167 to 231 (Table 2). 
In order to verify the DNA sequence variants detected 
by WES, the SNVs including some reported and novel 
genes through conventional Sanger sequencing method. 
In total, 12 reported candidate genes including IRF6, 
CRISPLD2, MYH9, PDGF-C and ABCA4 were detect-
ed by Sanger sequencing (Table 3). Except for the re-
ported genes, we found 16 novel SNVs were concordant 
with the gold standard method Sanger sequencing. The 
16 SNVs were present in two or more samples (Table 4, 
Fig. 2).
Discussion
NSCL/P is common craniofacial malformation with a 
complex and heterogeneous etiology.   In the present 
study, we applied WES to search for the genetic variants 
of 8 samples with NSCL/P. We identified 16 novel SNVs 
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Sample Raw SNVs SNVs in exon 
nonsynonymous 
SNVs 
SNVs filterd by 
public databases 
1 136019 18807 8546 196 
2 150712 18678 8577 198 
3 135602 19248 8868 231 
4 154660 19117 8722 219 
5 156568 19089 8759 222 
6 137949 18812 8502 218 
7 130211 18237 8327 167 
8 108409 18087 8300 174 
Mean 138766 18759 8575 203 









ABCA4 1 9446171 7 c.G6764T p.S2255I 1 
BMP4 14 54417522 c.T455C p.V152A 4 
CRISPLD2 16 84906098 c.C965G p.T322S 7 
EPHA3 3 89391019 c.T1085C p.I362T 1 
FGFR2 10 123310871 c.T212C p.M71T 1 
IRF6 1 209964080 c.G535A p.V179I 4 
MTHFR 1 11856378 c.C665T p.A222V 7 
MYH9 22 36684354 c.A4876G p.I1626V 6 
SPRY2 13 80911525 c.C316T p.P106S 7 
THADA 2 43797619 c.G2095A p.V699I 3 
PAX7 1 19071356 c.G1451A p.R484H 1 
PDGFC 4 157891963 c.G93T p.Q31H 1 










CENPJ 13 25487103 c.T61C p.M21V 7 
HEATR8 1 55136529 c.T1526C p.V509A 5 
REG3A 2 79385823 c.T149G p.H50P 3 
AQP7 9 33385852 c.C538T p.G180R 2 
C14orf49 14 95932477 c.T418C p.I140V 2 
COL4A2 13 111155786 c.G4096A p.D1366N 2 
EIF2B3 1 45340422 c.G1130A p.S377L 2 
KIF20B 10 91487648 c.A2146G p.N716D 2 
LACTB 15 63414085 c.C15T p.M5I 2 
PARVA 11 12539997 c.G1095C p.L365F 2 
PKP1 1 201286752 c.A899C p.N300T 2 
PRSS1 7 142460369 c.C542T p.S181N 2 
RECQL5 17 73627656 c.C1322T p.R441Q 2 
SEC16A 9 139358155 c.C4484T p.R1495Q 2 
TEX11 X 69772000 c.A2541C p.D847E 2 
YOD1 1 207224322 c.G54T p.F18L 2 
Table 4. Novel SNVs identified in NSCL/P using whole-exome sequencing and Sanger sequencing.
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shared by two or more affected samples which might 
play an important etiological role in NSCL/P. The study 
uncovered a list of susceptibility genes of NSCL/P and 
highlighted the important role of WES in identifying 
the etiology of NSCL/P.
Owing to its genetic heterogeneity and departure from 
Mendelian inheritance patterns, the identification of 
causative variants of NSCL/P has remained elusive. 
With the recent development of innovative approaches, 
whole-genome and WES projects become available 
now. WES has recently been successful in identifying 
causative genetic variants for Mendelian traits includ-
ing Miller syndrome and Kabuki syndrome (22,23). In 
one recent study, the WES was used to study potentially 
causal variants in affected relatives drawn from multi-
plex cleft families (24).  In our present study, we applied 
WES to identify genetic variants in Chinese subjects. 
We have shown WES may serve as a cost-effective and 
reproducible strategy for the identification of variants 
causing protein-coding changes in human genomes of 
NSCL/P. The average mean coverage sequencing depth 
on official target was 101.1-fold and with the average 
coverage of target region was 95.8%. Therefore, the 
coverage should have been adequate to reliably detect 
DNA variants within the majority of the targeted re-
gions. After filtering the SNVs not included in exons, 
the average number of SNVs per sample was 18,759 and 
the number of nonsynonymous SNVs was 8,575. This 
study indicates that the current WES protocol can dis-
sect the genetic etiology of NSCL/P. We speculate WES 
will be used in diagnosis of NSCL/P.
The susceptibility genes of NSCL/P are enormously 
diverse and complex screened by WES. The key chal-
lenge is how to identify the candidate genes from the 
large number of variants. In the present study, the av-
erage SNVs per sample were 18759 after filtering the 
SNVs not in exon. Even excluded the synonymous 
SNVs in the coding region, total 8575 exon nonsynony-
mous SNVs remained. We then applied NCBI dbSNP 
135 and 1000 Genomes Project for filtering of variants 
to remove common variants. The availability of NCBI 
dbSNP 135 and 1000 Genomes Project is clearly help-
ful in generating a catalogue of common variation and 
necessary for filtering out them. Combining the two 
catalogues, the number of candidates reduced consider-
ably and the susceptibility genetic variants list could be 
narrowed. Each sample carried 167 to 231 novel genetic 
variants with the average of 203. 
In this study, the reported candidate genes were vali-
dated using Sanger sequencing. The results were con-
sistent with some previous findings. The IRF6 variant 
known to be associated with NSCLP was also identi-
fied in these NSCLP-affected fetuses. In the studies of 
candidate genes for NSCL/P, many genes had positive 
Fig. 2. Heatmap of SNVs identified in 8 NSCL/P samples by whole-exome sequencing and 
Sanger sequencing. The DNA variants generated by whole-exome sequencing were verified 
by Sanger sequencing. The 16 types of SNVs were present in at least two samples. Therefore, 
whole-exome sequencing and Sanger sequencing confirmed 16 types of SNVs in at least 2 
samples needed to be further studied.
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results in one or more of the studies (5,11,13). However, 
only the positive association between IRF6 variants and 
NSCL/P has been confirmed in multiple populations 
of different ancestry (12,14,25). IRF6 is a key determi-
nant of the keratinocyte proliferation and differentiation 
switch and also plays a key role in the formation of oral 
periderm, spatio-temporal regulation of which is essen-
tial in ensuring appropriate palatal adhesion (29). The 
studies confirmed IRF6 gene was one of the main candi-
date genes associated with NSCLP. With the exception 
of IRF6, many other candidate genes were present in the 
susceptibility genes identified by WES. CRISPLD2 is 
expressed in the craniofacial region during critical time 
points of palatal fusion. Genetic variation in CRISPLD2 
has been shown to have a role in the etiology of NSCLP 
(27). MYH9, the gene coding for the heavy chain of 
non-muscle myosin II, has been considered as a good 
candidate gene in NSCL/P on the basis of its expression 
profile during craniofacial morphogenesis (26). The 
PDGF-C is essential for palatogenesis and is associated 
with NSCL/P (28). ABCA4 encodes an ATP-binding 
cassette transporter. A genome-wide association study 
of NSCL/P identifies risk variants near ABCA4 with 
stronger signals in Asian compared to European popula-
tions (16). The candidate genes associated with NSCL/P 
reported previously were identified in this study. The 
study suggests that direct sequencing of exons of small 
numbers of individuals can serve as a useful approach 
for identifying genetic variants of NSCL/P. As the costs 
of WES become more reasonable, we believe the project 
can be useful in clinical diagnosis of NSCL/P. 
However, this study failed to identify some reported 
candidate genes including FOXE1, NOG and VAX1. 
The gene FOXE1 variants involve all combinations of 
primary and secondary palatal clefts and have a sig-
nificant role in the etiology of NSCL/P (30). Mangold 
and colleagues identified two candidate genes NOG and 
VAX1 were associated with NSCL/P in populations 
from European ancestry (19). The failure to detect the 
association of the genes FOXE1, NOG and VAX1 with 
NSCL/P may due to small size of the study or genetic 
heterogeneity. 
In this study, Sanger sequencing was further applied 
to validate some novel genes. In total, 16 SNVs were 
present in two or more samples. The 16 SNVs may 
be predicted to lead to a significantly changed protein 
product. Then, the 16 nonsynonymous variants shared 
by two or more samples are highly likely to be causative 
for NSCL/P. Therefore, WES and Sanger sequencing 
confirmed 16 different types of prioritized SNVs asso-
ciated with NSCL/P.  Our study presented a prelimi-
nary overview of the genetic etiology of NSCL/P. The 
SNVs identified in the study may play important roles 
in susceptibility to NSCL/P. Although we were unable 
to confirm rigorously whether any of these genes in-
deed contributed to NSCL/P, our results provided a pri-
oritized shortlist for further association and validation 
studies. We speculate the susceptibility genes identified 
by WES may also contribute in some way to NSCL/P. 
These new candidates are needed be evaluated in future 
studies to establish their true relevance to NSCL/P sus-
ceptibility. Although the exact biological mechanism of 
the susceptibility genes involved in NSCL/P pathogen-
esis still needs to be clarified, genetic findings in this 
study will provide helps in diagnosis, counseling and 
treatment of NSCL/P.
In this study, we have demonstrated WES represents a 
cost-effective, reproducible and robust approach for re-
vealing the etiology of NSCL/P. We have successfully 
applied WES for genetic variants screening of NSCL/P. 
Our study has generated a list of susceptibility genes 
of NSCL/P to lead to a full understanding of NSCL/P 
and improved information and clinical applications for 
affected individuals. The susceptibility genes identified 
in fetuses affected by NSCLP may lead to improved di-
agnosis, counseling and treatment.
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